Cambridge Brain Sciences Inc. (o/a Creyos)

Creyos is a Toronto-based digital health platform specializing in scientifically validated cognitive and behavioral health assessments. Built on 30+ years of neuroscience research and supported by 400+ peer-reviewed studies, the platform delivers 12 validated cognitive tasks that assess short-term memory, reasoning, attention, verbal ability, decision-making capacity, and executive function. Designed for seamless in-clinic or remote deployment without specialized equipment, Creyos generates real-time reports supporting early detection and monitoring of cognitive impairment, mild cognitive impairment (MCI), dementia, ADHD, Parkinson's disease, traumatic brain injury, and behavioral health conditions. The platform integrates with existing clinical workflows, supports both fee-for-service and value-based care models, and includes digital questionnaires for behavioral evaluation. Features include audio and visual guidance, multi-lingual support, and HIPAA-compliant data security. Used by 10,000+ healthcare providers including primary care, neurology, psychiatry, and specialized rehabilitation centers.